Dornan David 4
4 · Elevation Oncology, Inc. · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Dornan David
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-14+230,000→ 230,000 totalExercise: $2.65Exp: 2032-03-13→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on March 14, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer.